Literature DB >> 6802719

IgE myeloma. Report of a new case and review of the literature.

P Sala, E Tonutti, M Ruscio, R Colle, G Antonutto, G Falconieri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6802719

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.

Authors:  A Genovese; J P Bouvet; G Florio; B Lamparter-Schummert; L Björck; G Marone
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  IgE myeloma associated with plasma cell leukaemia.

Authors:  N C West; A M Smith; R Ward
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

3.  In vitro production of IgE by human peripheral blood mononuclear cells. III. Demonstration of a circulating IgE-bearing cell involved in the spontaneous IgE biosynthesis.

Authors:  S Romagnani; G Damiani; M G Giudizi; R Biagiotti; F Almerigogna; G F Delprete; E Maggi; A Bargellesi; M Ricci
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

4.  IgE myelomatosis. Presentation of a new case and summary of literature.

Authors:  S Hegewisch; K Mainzer; D Braumann
Journal:  Blut       Date:  1987-07

5.  Mechanism of activation of human basophils by Staphylococcus aureus Cowan 1.

Authors:  G Marone; M Tamburini; M G Giudizi; R Biagiotti; F Almerigogna; S Romagnani
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors.

Authors:  Leonardo Cristinziano; Remo Poto; Gjada Criscuolo; Anne Lise Ferrara; Maria Rosaria Galdiero; Luca Modestino; Stefania Loffredo; Amato de Paulis; Gianni Marone; Giuseppe Spadaro; Gilda Varricchi
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.